旭富

+0.40 (+0.69%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

58.30342成交張數116.60本益比1.31股價淨值比1.29%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	69	53	23.3%	1.25	44.44	1.1%	0.9%	1.6	0.9
2026Q1	70	54	22.2%	1.05	45.27	1.8%	1.4%	0.4	-0.1
2025Q4	69	54	21.7%	1.05	45.14	2.0%	1.5%	0.6	-0.3
2025Q3	69	54	21.6%	1.10	44.94	2.1%	1.6%	-0.3	-1.6
2025Q2	70	54	23.3%	1.23	45.04	9.3%	7.0%	0.8	-0.3
2025Q1	71	55	21.8%	1.53	46.33	9.8%	7.6%	1.1	-1.1
2024Q4	72	55	23.9%	1.64	45.83	10.1%	7.7%	7.9	2.1
2024Q3	72	54	25.0%	2.35	45.36	10.1%	7.6%	0.6	-0.7
2024Q2	68	51	26.1%	2.59	42.26	3.0%	2.3%	-1.0	-1.6
2024Q1	67	51	23.2%	4.13	43.03	6.3%	4.6%	1.2	0.1
2023Q4	67	51	23.8%	3.43	42.67	6.8%	5.1%	0.3	-2.1
2023Q3	56	41	25.7%	1.99	38.40	9.8%	7.4%	0.7	-2.5
2023Q2	54	41	24.1%	1.86	43.08	10.2%	7.8%	2.7	1.7
2023Q1	52	37	29.3%	1.15	38.68	9.4%	6.9%	-1.5	-3.7
2022Q4	50	36	26.8%	1.35	38.05	8.9%	6.8%	0.6	-3.3
2022Q3	46	36	23.0%	1.48	37.30	6.1%	4.7%	1.3	-1.6
2022Q2	46	35	23.1%	1.71	36.82	5.6%	4.3%	3.6	2.4
2022Q1	44	34	23.2%	1.61	35.43	1.6%	1.3%	-2.5	-5.5
2021Q4	42	33	20.8%	1.87	34.81	1.7%	1.3%	0.2	-3.8
2021Q3	43	34	21.4%	2.25	35.12	-5.8%	-4.8%	2.1	1.8
2021Q2	43	33	21.5%	2.55	42.02	-1.3%	-1.0%	-1.7	-2.4
2021Q1	45	33	24.9%	1.80	42.10	5.5%	4.4%	2.3	2.1
2020Q4	46	33	27.3%	1.71	41.80	10.6%	8.3%	2.4	1.9
2020Q3	42	36	14.5%	2.39	45.68	20.8%	17.8%	2.3	1.9
2020Q2	46	34	25.9%	2.11	43.28	21.1%	15.9%	2.5	2.2
2020Q1	43	36	15.4%	3.41	45.90	17.5%	14.9%	2.6	2.4
2019Q4	41	35	14.9%	3.31	43.71	17.1%	14.5%	2.5	2.1
2019Q3	40	34	14.3%	3.37	42.64	18.2%	15.5%	1.7	1.2
2019Q2	41	32	22.8%	2.22	40.17	18.1%	14.4%	0.8	0.5
2019Q1	40	34	15.3%	3.24	42.36	17.3%	14.9%	2.9	2.3
2018Q4	38	32	15.3%	3.07	40.39	14.6%	12.6%	1.3	0.4
2018Q3	37	31	16.2%	2.85	39.01	13.3%	11.4%	1.5	1.4
2018Q2	36	30	18.4%	2.60	37.36	10.7%	8.6%	1.2	1.1
2018Q1	34	30	11.7%	3.79	37.64	6.6%	5.8%	0.8	0.5
2017Q4	33	29	11.1%	3.90	36.86	6.4%	5.6%	1.7	1.2
2017Q3	33	29	11.9%	3.63	36.11	5.6%	5.0%	0.0	-0.2
2017Q2	36	28	21.2%	2.26	35.60	7.6%	6.0%	0.1	-0.1
2017Q1	35	31	11.6%	4.13	39.29	10.3%	8.7%	1.0	0.9
2016Q4	36	31	13.5%	3.56	38.64	–	–	1.6	1.4
2016Q3	34	30	11.7%	3.98	38.21	–	–	1.4	1.2